Related Experiment Videos

Functions of polymorphonuclear (PMN) leukocytes of patients with lymphoproliferative diseases

Immunology Letters
|January 1, 1985
PubMed

Insights

Polymorphonuclear (PMN) leukocytes from multiple myeloma (MM) patients showed impaired function. Patients with Hodgkin

Area of Science:

  • Hematology
  • Immunology
  • Oncology

Background:

  • Leukocyte dysfunction is observed in various hematologic malignancies.
  • Understanding immune cell function in untreated cancers is crucial for prognosis.

Purpose of the Study:

  • To investigate the phagocytic and chemotactic functions of polymorphonuclear (PMN) leukocytes in patients with multiple myeloma (MM), Hodgkin's disease (HD), and non-Hodgkin lymphoma (NHL).
  • To assess alkaline phosphatase score and nitroblue tetrazolium (NBT) reduction in leukocytes from these patient groups.

Main Methods:

  • In vitro analysis of PMN leukocyte phagocytosis and chemotaxis.
  • Determination of alkaline phosphatase score and NBT reduction.
  • Comparison with control leukocytes.

Main Results:

  • PMN leukocytes from untreated MM patients exhibited significantly impaired phagocytic and chemotactic functions compared to controls.
  • PMN leukocytes from untreated HD and NHL patients showed impaired chemotaxis towards casein and endotoxin-activated serum (EAS), but other functions remained largely intact.
  • Alkaline phosphatase score and NBT reduction varied across patient groups.

Conclusions:

  • Multiple myeloma is associated with a broad impairment of PMN leukocyte functions.
  • Hodgkin's disease and non-Hodgkin lymphoma primarily affect the chemotactic response of PMN leukocytes.
  • These findings highlight differential impacts of hematologic malignancies on innate immune cell function.

Related Concept Videos